These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 16254684

  • 1. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
    Okobia M, Bunker C, Zmuda J, Kammerer C, Vogel V, Uche E, Anyanwu S, Ezeome E, Ferrell R, Kuller L.
    Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
    [Abstract] [Full Text] [Related]

  • 2. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 3. [Study on serum organochlorines pesticides (DDTs) level, CYP1A1 genetic polymorphism and risk of breast cancer: a case control study].
    Li JY, Wu DS, Yang F, Zeng HY, Lei FM, Zhou WD, Li H, Tao P.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Mar; 27(3):217-22. PubMed ID: 16792888
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, Zheng W.
    Cancer; 2005 Jun 01; 103(11):2228-35. PubMed ID: 15856430
    [Abstract] [Full Text] [Related]

  • 5. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y, Li DK, Wu J, Zhang Z, Gao E.
    Cancer Epidemiol Biomarkers Prev; 2006 Feb 01; 15(2):342-7. PubMed ID: 16492926
    [Abstract] [Full Text] [Related]

  • 6. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P, Joseph T, Mathew BS, Rajan B, Pillai MR.
    Mutat Res; 2005 Mar 07; 581(1-2):153-63. PubMed ID: 15725614
    [Abstract] [Full Text] [Related]

  • 7. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.
    Cancer Res; 1998 Feb 15; 58(4):667-71. PubMed ID: 9485019
    [Abstract] [Full Text] [Related]

  • 8. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
    Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, Pillai MR.
    Gynecol Oncol; 2006 Jun 15; 101(3):411-7. PubMed ID: 16360200
    [Abstract] [Full Text] [Related]

  • 9. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 15; 13(8):1407-11. PubMed ID: 15298966
    [Abstract] [Full Text] [Related]

  • 10. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population.
    Pandey SN, Choudhuri G, Mittal B.
    Eur J Cancer Prev; 2008 Apr 15; 17(2):77-81. PubMed ID: 18287863
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer RiskHeidelberg, Germany..
    Breast Cancer Res Treat; 2010 Jan 15; 119(2):463-74. PubMed ID: 19424794
    [Abstract] [Full Text] [Related]

  • 12. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study.
    Laden F, Ishibe N, Hankinson SE, Wolff MS, Gertig DM, Hunter DJ, Kelsey KT.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 15; 11(12):1560-5. PubMed ID: 12496044
    [Abstract] [Full Text] [Related]

  • 13. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D.
    Mutat Res; 2008 Mar 01; 639(1-2):1-10. PubMed ID: 18082227
    [Abstract] [Full Text] [Related]

  • 14. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y, Shu XO, Cai Q, Jin F, Cheng JR, Cai H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1096-101. PubMed ID: 15894658
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB.
    Carcinogenesis; 2007 Jul 01; 28(7):1455-62. PubMed ID: 17307803
    [Abstract] [Full Text] [Related]

  • 16. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
    Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y.
    Acta Oncol; 2006 Jul 01; 45(5):597-601. PubMed ID: 16864175
    [Abstract] [Full Text] [Related]

  • 17. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N, Cai Q, Xu WH, Xiang YB, Cai H, Zheng W, Shu XO.
    Cancer; 2007 Apr 01; 109(7):1296-302. PubMed ID: 17315164
    [Abstract] [Full Text] [Related]

  • 18. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk.
    Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A.
    Cancer Res; 1995 Aug 15; 55(16):3483-5. PubMed ID: 7627950
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS, Mandhani A, Mittal RD.
    Arch Toxicol; 2008 Sep 15; 82(9):633-9. PubMed ID: 18200441
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV, Calle EE, Pavluck AL, Feigelson HS, Thun MJ, Rodriguez C.
    Breast Cancer Res; 2005 Sep 15; 7(6):R1168-73. PubMed ID: 16457697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.